INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
18/08/2022
Voltar para busca
Dado oficial do USPTO
HUTRIGEL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
18/08/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
26/05/2020
Data de registro
17/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/08/2021
Última transação
17/08/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
KR
Examinador
BIFTU, BENIAM
Unidade examinadora
M80
Localização atual
TMO LAW OFFICE 117
Titulares e representantes
Titulares
HLB CELL CO.,LTD
Representantes
Kisuk Lee Harness, Dickey & Pierce, PLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cell growth media for growing cells for use in scientific and research use; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; reagents for scientific purposes; chemical preparations for scientific purposes other than for medical or veterinary use; biological preparations for use in biotechnological product development other than medical or veterinary use; biochemicals for in vitro and in vivo scientific use; reagents for research purposes; reagents for medical research; collagen used as a raw ingredient in the manufacture of cosmetics; collagen peptides for cosmetics; collagen for use as a raw ingredient in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; cells for scientific or laboratory purposes; biological preparations for scientific purposesother than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological materialcell culture media for scientific and research use *not for medical or veterinary purposes * ; Biological preparationsextracellular matrix for cell cultures for use in scientific research *not for medical or veterinary purposes * ; biological preparationtype 4 collagen and laminin for bioprinting for industrial use *not for medical or veterinary purposes * ; biological material for bioprintingtype 4 collagen and laminin *not for medical or veterinary purposes *
Classe 5
Pharmaceutical preparations for skin care; drug delivery agents in the form of solutiongelpowder that facilitate the delivery of pharmaceutical preparations; medicament formulating agents for promoting wound healing of damaged epithelial tissuesconnective tissuesnervous tissuesdental tissues; biological preparations for medical or veterinary purposesfor the treatment of traumatic woundburnulcercorneal diseasesmucosal and submucosal injuriesnerve injuriesinternal organ injuriestendon and ligament injuriesdental diseases; culture media for medical use; biotechnological preparations for medical purposesbiotechnologically-formed proteins for the treatment of traumatic woundburnulcercorneal diseasesmucosal and submucosal injuriesnerve injuriesinternal organ injuriestendon and ligament injuriesdental diseases; cellular function activating agents for medical purposes; Medicated skin care preparations for medical purposes; collagen for medical purposes; pharmaceutical compositionspharmaceutical preparations for promoting wound healing of damaged epithelial tissuesconnective tissuesnervous tissuesdental tissues; surgical implants comprised of living tissues; Natural biomaterials for tissue restoration for medical purposes; implants comprising living tissue for guided tissue regeneration; implantable materials comprising living tissue for use in guided tissue regeneration; surgical implants comprising living tissuesstem cells; extracellular matrixtype 4 collagenlaminin for medical purposes; Bone void fillers consisting of biological materials for medical purposes; biological preparations for medical purposesfor the treatment of traumatic woundburnulcercorneal diseasesmucosal and submucosal injuriesnerve injuriesinternal organ injuriestendon and ligament injuriesdental diseases; biological tissue cultures for medical purposes; biological tissue culture media for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
18/06/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
20/02/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
31/01/2022
FIMP
FINAL DISPOSITION PROCESSED
31/01/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/11/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
21/10/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/10/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
18/10/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
19/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
17/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/06/2021
PUBO
PUBLISHED FOR OPPOSITION
01/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
23/04/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/04/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
23/04/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/04/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/04/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/04/2021
RFNT
REFUSAL PROCESSED BY IB
14/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/10/2020
RFRR
REFUSAL PROCESSED BY MPU
24/10/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/10/2020
CNRT
NON-FINAL ACTION WRITTEN
01/10/2020
DOCK
ASSIGNED TO EXAMINER
30/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/09/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HUTRIGEL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.